Zivana Tezak PhD, MSc

Živana Tezak, Ph.D., is an Associate Director for Science and Technology, Personalized Medicine Staff, in the Office of In Vitro Diagnostic Device (IVD) Evaluation and Safety (OIR), at the Center for Devices and Radiological Health, Food and Drug Administration (FDA). Prior to joining the FDA in 2004, Dr. Tezak worked in biotechnology industry, holding research and development positions in a bioinformatics and array developer company. After receiving her Ph.D. from Florida State University,
Dr. Tezak was a research fellow at the University of Pittsburgh Medical Center and Children’s National Medical Center, Research Center for Genetic Medicine, working on neuromuscular disorders, human genetics, gene therapy and high-throughput screening technologies. In her current position at the FDA, Dr. Tezak has been leading efforts to develop flexible regulatory policies for novel technology based clinical diagnostic tests, such as next generation sequencing, in order to enable their smoother translation into the clinic.